Recently, the National Medical Security Administration has made work arrangements for improving and improving the functions of the centralized pharmaceutical procurement platform and supporting the reform and management of pharmaceutical prices.
The National Medical Insurance Administration emphasized that the centralized pharmaceutical procurement platform is the basic support for the centralized procurement of drugs and medical consumables, and the promotion of pharmaceutical price reform and management. It must be guided by Xi Jinping Thought on Socialism with Chinese Characteristics for a New Era, and adhere to demand-oriented, standard-led, systematic Integrate, reform and innovate, further improve and improve the functions of the platform, promote the formation of a medical supply guarantee system, and improve the modernization level of medical price governance.
The National Medical Insurance Administration pointed out that it is necessary to better support centralized procurement with volume, support the normalization and institutionalization of centralized procurement with volume, and provide technical support for consolidating the reform of centralized procurement with volume. Expand the coverage of the platform and expand the main body of procurement to cover all public medical institutions. Strengthen the monitoring of medical prices, improve the monitoring system, expand the scope and content of monitoring, strengthen the construction of medical price monitoring capabilities, and promote the application of monitoring information and data. Establish a collaborative linkage mechanism, improve the level of data connectivity and sharing between platforms, such as price, credit evaluation, and supply, and promote the formation of a unified and open centralized procurement market across the country.
The National Medical Insurance Administration also put forward a number of measures to strengthen transaction service support, improve payment settlement methods, strengthen monitoring and supervision capabilities, improve overall service levels, and improve supporting measures. Create a number of demonstration platforms for centralized pharmaceutical procurement with complete functions, efficient operation, convenient services and social satisfaction across the country, and summarize and form typical experiences that can be promoted and replicated. By the end of the "14th Five-Year Plan" period, a centralized pharmaceutical procurement management system with business standardization, management standardization and service specialization as the core will be fully established. The operation of the centralized procurement platform will be more orderly, convenient and efficient. The level of professional services has been significantly improved.